Skip to main content

Table 1 Characteristics of the 43 included studies

From: Loss of alanine-glyoxylate and serine-pyruvate aminotransferase expression accelerated the progression of hepatocellular carcinoma and predicted poor prognosis

Article

Year of publication

Country

NP

NG

Tissue

C&A

Etiology

Engelmann [14]

2015

Germany

15

30

F

T

 

Itzel [15]

2015

USA

163

61

F

F

 

Yu [16]

2015

China

154

67

T

F

HBV

Shi [17]

2014

China and Singapore

26

6

T

F

 

Mayinuer [18]

2013

Japan

152

154

T

F

 

Gehrau [19]

2012

USA

107

17

F

F

HCV

Nagai [11]

2012

Japan

21

25

T

F

HCV

Roessler [20]

2012

China

76

6

F

F

HBV

Sato [21]

2012

Japan

48

20

T

F

HCV

Yu [22]

2012

China

100

59

T

F

HBV

Zekri [23]

2012

Egypt

31

25

T

T

HCV

Satow [24]

2010

Japan

84

124

T

T

 

De Giorgi [25]

2009

Italy

21

39

F

F

HCV

Sugawara [26]

2010

Japan

1CL

36

F

F

 

Derambure [12]

2008

France

40

63

T

F

HBV, HCV, alcoholism

Gao [9]

2008

Japan

38

24

T

T

HCV, HBV

Guo [27]

2008

China

3CL

17

F

F

 

Hamaguchi [10]

2008

Japan

60

22

T

F

 

Kittaka [5]

2008

Japan

100

25

T

F

HCV, HBV

Sakai [13]

2008

Japan

12

93

F

T

HCV

Skawran [28]

2008

Germany

32

185

F

F

HBV, HCV

Yamashita [29]

2008

China

40

71

T

F

HBV

Lin [30]

2007

Taiwan

–

19

F

F

 

Liu [31]

2007

China

1

45

T

F

 

Wang [32]

2007

Singapore

80

57

T

F

HCV, HBV

Wang [33]

2007

USA

14

134

F

F

 

Danenberg [34]

2006

USA

1CL

50

F

F

 

Chen [35]

2005

USA

63

54

F

F

 

Ge [36]

2005

Japan

36

58

F

F

 

Iizuka [37]

2005

Japan

76

110

T

F

HCV, HBV

Matoba [38]

2005

Japan

33

46

T

F

HCV, HBV

Nam [6]

2005

Korea

42

92

T

F

 

Wong [39]

2005

China

10

55

F

F

HBV, HCV

Breuhahn [40]

2004

Germany

39

118

T

T

HBV, HCV, alcoholism

Chen [41]

2004

USA

–

29

T

F

 

Lee [7]

2004

Korea

10

20

T

F

HCV, HBV

Kurokawa [42]

2004

Japan

20

63

T

F

HBV, HCV

Smith [8]

2003

USA

20

50

T

F

HCV

Kim [43]

2003

USA

74

30

T

F

 

Chung [44]

2002

Korea

8

62

T

T

 

Iizuka [45]

2002

Japan

51

83

T

F

HBV, HCV

Lee [46]

2002

USA

19CL

119

F

F

 

Okabe [47]

2001

Japan

20

–

T

T

HBV, HCV

  1. NP number of patients, NG number of significant genes, Tissue clinical tissue, C&A contain adjacent tissue, CL cell line, T true, F false